Saskia Vosslamber - Concepedia

Author

Saskia Vosslamber

Amsterdam UMC Location Vrije Universiteit Amsterdam

Also Known As

S Vosslamber, S. Vosslamber, Saskia Vosslamber, Vosslamber, S.

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Amsterdam UMC Location Vrije Universiteit Amsterdam Reade Institute of Rheumatology Karolinska Institutet Academic Center for Dentistry Amsterdam

About

Saskia Vosslamber is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in autoimmune disease, immunology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	223
2	Immunology	7	7	223
3	Allergy	3	3	87
4	Biostatistics	1	1	29
5	Molecular Medicine	1	1	20

Saskia Vosslamber

Publications

Citations

H-Index

Page 1

	Year	Citations
The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients Hennie G. Raterman, Saskia Vosslamber, Sander de Ridder, Arthritis Research & Therapy	2012	184
The type I IFN signature as a biomarker of preclinical rheumatoid arthritis Joyce Lübbers, Mikael Brink, Lotte A van de Stadt, Annals of the Rheumatic Diseases	2013	157
Pharmacogenomics of Interferon-ß Therapy in Multiple Sclerosis: Baseline IFN Signature Determines Pharmacological Differences between Patients Lisa G. M. van Baarsen, Saskia Vosslamber, Marianne Tijssen, PLoS ONE	2008	114
Methotrexate Normalizes Up‐Regulated Folate Pathway Genes in Rheumatoid Arthritis Marjolein Blits, Gerrit Jansen, Yehuda G. Assaraf, Arthritis & Rheumatism	2013	66
Arming the Melanoma Sentinel Lymph Node through Local Administration of CpG-B and GM-CSF: Recruitment and Activation of BDCA3/CD141+ Dendritic Cells and Enhanced Cross-Presentation Berbel J.R. Sluijter, Mari F.C.M. van den Hout, Bas D. Koster, Cancer Immunology Research	2015	61
Pharmacological induction of interferon type I activity following treatment with rituximab determines clinical response in rheumatoid arthritis Saskia Vosslamber, Hennie G. Raterman, Tineke C. T. M. van der Pouw Kraan, Annals of the Rheumatic Diseases	2011	59
Effect of prednisone on type I interferon signature in rheumatoid arthritis: consequences for response prediction to rituximab Tamarah D. de Jong, Saskia Vosslamber, Marjolein Blits, Arthritis Research & Therapy InflammationRheumatologyRheumatoid DisorderAutoimmune DiseaseMedicine	2015	56
Changes in peripheral blood lymphocyte subsets during arthritis development in arthralgia patients Joyce Lübbers, Marian H. van Beers-Tas, Saskia Vosslamber, Arthritis Research & Therapy	2016	52
Autoantibody Specificities and Type I Interferon Pathway Activation in Idiopathic Inflammatory Myopathies Louise Ekholm, Saskia Vosslamber, Anna Tjärnlund, Scandinavian Journal of Immunology ImmunohematologyImmunodeficienciesImmunologyPathologyWhole Blood	2016	38
Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonβ therapy in multiple sclerosis Saskia Vosslamber, L.F. van der Voort, I.J. van den Elskamp, Genes and Immunity Autoimmune DiseaseInterferonβ TherapyMedicineImmunodeficienciesNeurological Disorder	2011	34

Page 1